CASEYS GENERAL STORES INC

CASY

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Not Applicable** This position is in Casey's General Stores (CASY), a convenience store retailer—not a biotech company.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 41,233Value: $22.8M

**Signal Note: Not Applicable** This position is in Casey's General Stores (CASY), a convenience store retailer—not a biotech company. Driehaus's biotech-focused portfolio initiating a $22.8M position in a non-pharma asset suggests either portfolio diversification into defensive/value holdings or a tactical shift away from biotech exposure at current valuations. This is a notable signal for Driehaus's near-term positioning rather than a clinical/commercial biotech development.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: